Cited by 39Epilepsy research and treatmentNeuroscience and Neuropharmacology ResearchDiet and metabolism studies

Hippocampal neuro-networks and dendritic spine perturbations in epileptogenesis are attenuated by neuroprotectin D1

Open access
Musto, Alberto E., Walker, Chelsey P., Petasis, Nicos A., Bazan, Nicolas G.·2015·PLOS ONE

Abstract

PURPOSE: Limbic epileptogenesis triggers molecular and cellular events that foster the establishment of aberrant neuronal networks that, in turn, contribute to temporal lobe epilepsy (TLE). Here we have examined hippocampal neuronal network activities in the pilocarpine post-status epilepticus model of limbic epileptogenesis and asked whether or not the docosahexaenoic acid (DHA)-derived lipid mediator, neuroprotectin D1 (NPD1), modulates epileptogenesis. METHODS: Status epilepticus (SE) was induced by intraperitoneal administration of pilocarpine in adult male C57BL/6 mice. To evaluate simultaneous hippocampal neuronal networks, local field potentials were recorded from multi-microelectrode arrays (silicon probe) chronically implanted in the dorsal hippocampus. NPD1 (570 μg/kg) or vehicle was administered intraperitoneally daily for five consecutive days 24 hours after termination of SE. Seizures and epileptiform activity were analyzed in freely-moving control and treated mice during epileptogenesis and epileptic periods. Then hippocampal dendritic spines were evaluated using Golgi-staining. RESULTS: We found brief spontaneous microepileptiform activity with high amplitudes in the CA1 pyramidal and stratum radiatum in epileptogenesis. These aberrant activities were attenuated following systemic NPD1 administration, with concomitant hippocampal dendritic spine protection. Moreover, NPD1 treatment led to a reduction in spontaneous recurrent seizures. CONCLUSIONS: Our results indicate that NPD1 displays neuroprotective bioactivity on the hippocampal neuronal network ensemble that mediates aberrant circuit activity during epileptogenesis. Insight into the molecular signaling mediated by neuroprotective bioactivity of NPD1 on neuronal network dysfunction may contribute to the development of anti-epileptogenic therapeutic strategies.

AI snapshot

Written from the paper’s full text.

TL;DR

In a pilocarpine post-status epilepticus mouse model, hippocampal epileptogenesis was accompanied by brief high-amplitude microepileptiform activity (MEA), low-voltage activity, and dendritic spine loss. Systemic neuroprotectin D1 (NPD1) given for five days after status epilepticus attenuated MEA, reduced spontaneous recurrent seizures, and protected hippocampal dendritic spines.

Key findings

  • During epileptogenesis at 7 days post-SE, mice showed brief spontaneous MEA not seen in controls: 4.6 ± 1.06 events per delta epoch, duration 0.8 ± 0.14 sec, with high amplitude mainly in CA1 pyramidal and stratum radiatum layers.
  • NPD1 reduced MEA number (NPD1 0.8 ± 0.28 vs vehicle 2.09 ± 0.15, P = 0.007) and duration (NPD1 0.7 ± 0.07 vs vehicle 1.72 ± 0.2, P = 0.013), and reduced high-frequency activity above 200 Hz in the dentate gyrus.
  • At three weeks after SE, NPD1-treated mice had reduced spontaneous recurrent seizure severity (Racine score 1.2 ± 0.2 vs vehicle 3.16 ± 0.6, P = 0.0019), duration (2.74 ± 0.72 vs 7.23 ± 0.6, P = 0.014), and spike number (1.5 ± 0.86 vs 21.93 ± 3.23, P = 0.009).
  • SE reduced dendritic spine density in CA1 stratum radiatum (control 0.78 ± 0.06 vs epileptogenesis 0.62 ± 0.03, p = 0.03) and dentate gyrus (control 0.82 ± 0.054 vs epileptogenesis 0.67 ± 0.03, p = 0.02); NPD1-treated mice showed higher spine density than vehicle-treated mice across hippocampal layers and fewer beading-like profiles.

Methods

  • Status epilepticus was induced with pilocarpine hydrochloride (250 mg/kg i.p.) after methyl scopolamine nitrate (1 mg/kg i.p.) in 52 adult male C57BL/6 mice; 45 survived (60%), and controls (n = 10) received methyl scopolamine.
  • A 16-electrode silicon probe was implanted in the dorsal hippocampus; local field potentials were recorded in freely-moving mice on day 7 and days 21–28 after SE, with seizures scored by Racine scale and dendritic spines assessed by Golgi staining at 7 days post-SE.
  • NPD1 (570 μg/kg) or vehicle was administered i.p. daily for five consecutive days starting 24 hours after SE termination; data were analyzed with means ± S.E.M., t-tests, ANOVA with post-hoc tests, and cumulative probability/log-rank tests.

Limitations

  • The paper does not include a dedicated limitations section. It states that the precise neurotransmission mechanism mediated by NPD1 in epileptogenesis remains to be further defined and that further studies are needed.
  • Evident from the text: small group sizes (e.g., LFP n = 7 per group; seizure analysis n = 5 NPD1 vs n = 6 vehicle; spine analysis n = 4 per group; PSE vs control n = 3), use of only adult male C57BL/6 mice, a single pilocarpine model, and no dose-response or long-term follow-up beyond approximately three weeks after SE.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.1371/journal.pone.0116543

Cites

59 of 59 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Claims the paper makes

0 of 55 cited sources checked · 0 supported · 0 flagged

  • Findingown data

    NPD1 administration protects hippocampal dendritic spines in epileptogenesis.

    “These aberrant activities were attenuated following systemic NPD1 administration, with concomitant hippocampal dendritic spine protection.”
    • Also stated in: § Introduction · plain
      “We observed that NPD1 reduces brief spontaneous epileptiform field potentials and dendritic spine loss in the dorsal hippocampus, with resultant limited hippocampal epileptic activity.”
    Quote in the paperSubstantial claim
    • Rests on an assumption: NPD1 administered intraperitoneally at 570 μg/kg for five consecutive days reaches the hippocampus and engages neuroprotective signaling.
    • Rests on an assumption: Dendritic spine number measured by Golgi staining is a valid proxy for synaptic integrity and network function.
  • Findingown data

    Attenuation of low frequency bands (delta, theta, beta, gamma) is present in all hippocampal layers except theta in SO and PYR during epileptogenesis.

    “In addition, attenuation of low frequency bands (i.e., delta, theta, beta and gamma) were present in all hippocampal layers except theta, in the SO and PYR (Fig. 3).”
    Quote in the paperNot a substantial claim
  • Findingown data

    Brief spontaneous microepileptiform activity with high amplitudes occurs in the CA1 pyramidal and stratum radiatum during epileptogenesis.

    “We found brief spontaneous microepileptiform activity with high amplitudes in the CA1 pyramidal and stratum radiatum in epileptogenesis.”
    • Also stated in: § Results · plain
      “LVA was interrupted by an unexpected brief spontaneous micro-epileptiform activity (MEA) (Fig. 2B).”
    • Also stated in: § Results · plain
      “MEA was characterized by successive bursts of spikes with high amplitudes (Fig. 2B), mainly in the PYR and RAD (P = 0.007 vs. LVA) (Fig. 2E) simultaneously in all hippocampal layers (4.6 ± 1.06 events/per delta epoch; with duration of 0.8 sec ± 0.14 sec) (Fig. 2 B–D).”
    Quote in the paperSubstantial claim
  • Findingown data

    At seven days after SE, the dorsal hippocampus displays disruptions in electrical patterns in all hippocampal layers.

    “At seven days after SE and during periods of immobility in freely-moving mice, although convulsive seizures were not observed (Racine’s score > 3), consistent with previous observations [34, 35] the dorsal hippocampus displayed disruptions in electrical patterns, mainly in all hippocampal layers (Fig. 2A).”
    Quote in the paperSubstantial claim0 of 2 sources checked
    • cites [34] J Seo, 2012, Early deficits in social behavior and cortical rhythms in pilocarpine-induced mouse model of temporal lobe epilepsy, Exp Neurol S0014–4886

      Not checked in the free run.

    • cites [35] H Shibley, 2002, Pilocarpine-induced status epilepticus results in mossy fiber sprouting and spontaneous seizures in C57BL/6 and CD-1 mice, Epilepsy Res source

      Not checked in the free run.

  • Findingown data

    NPD1 administration attenuates aberrant microepileptiform activities in epileptogenesis.

    “These aberrant activities were attenuated following systemic NPD1 administration, with concomitant hippocampal dendritic spine protection.”
    • Also stated in: § Introduction · plain
      “We observed that NPD1 reduces brief spontaneous epileptiform field potentials and dendritic spine loss in the dorsal hippocampus, with resultant limited hippocampal epileptic activity.”
    Quote in the paperSubstantial claim
    • Rests on an assumption: NPD1 administered intraperitoneally at 570 μg/kg for five consecutive days reaches the hippocampus and engages neuroprotective signaling.
  • May combine two claims. 19
  • Classified as probably not a substantial claim. 18
  • May combine two claims.

    Findingown data

    NPD1 provides protection for dendrites and dendritic spines during epileptogenesis, reaching a similar number of dendrites as control animals.

    “we showed that NPD1 could provide protection for dendrites and dendritic spines during epileptogenesis, which reached up to a similar number of dendrites for animals from the control group (S2 Fig.: CA1 L-M: NPD1 1 ± 0.08 S.E.M. vs. Control: 0.82 ± 0.16 S.E.M., p: 0.2; DG: NPD1: 1.18 ± 0.10 S.E.M. vs. Control: 1.14 ± 0.11 S.E.M., p: 0.7)”
    Quote in the paperSubstantial claim
  • May combine two claims.

    Findingown data

    MEA is characterized by successive bursts of spikes with high amplitudes, mainly in PYR and RAD, simultaneously in all hippocampal layers, with 4.6 ± 1.06 events per delta epoch and duration 0.8 ± 0.14 sec.

    “MEA was characterized by successive bursts of spikes with high amplitudes (Fig. 2B), mainly in the PYR and RAD (P = 0.007 vs. LVA) (Fig. 2E) simultaneously in all hippocampal layers (4.6 ± 1.06 events/per delta epoch; with duration of 0.8 sec ± 0.14 sec) (Fig. 2 B–D).”
    Quote in the paperNot a substantial claim
  • May combine two claims.

    Findingown data

    Spontaneous isolated spikes were observed in only 66% of mice after SE, not statistically different from controls.

    “In addition to different patterns from MEA, spontaneous isolated spikes were observed in only 66% of mice after SE; however these were not statistically different from controls that showed similar spike profiles (P = 0.09 vs. control) (S1 Fig.).”
    Quote in the paperNot a substantial claim
  • May combine two claims.

    Findingown data

    Within MEA, high frequency activity is present associated with a peak of 120 Hz in all hippocampal layers and a trend of higher frequency bands in RAD.

    “Also, within the MEA, high frequency activity was present associated with a peak of 120 Hz in all hippocampal layers and a trend of higher frequency bands in the RAD (Fig. 4B).”
    Quote in the paperNot a substantial claim
  • May combine two claims.

    Findingown data

    MEA shows reduction of power in low frequency bands, especially delta and beta in OR and DG, compared with controls, and a trend of increased gamma waves in all layers.

    “These MEA showed reduction of the power in the low frequency bands, especially in delta and beta in the OR and DG, compared with controls (Fig. 4A); a trend of increased gamma waves occurred in all layers observed.”
    Quote in the paperNot a substantial claim
  • May combine two claims.

    Premisecitation

    Omega-3 essential fatty acid improves neurological outcomes in models of epilepsy and is neuroprotective.

    “Recent evidence suggests that omega-3 essential fatty acid improves neurological outcomes in models of epilepsy [14, 15] and is neuroprotective [12, 16, 17].”
    Quote in the paperNot a substantial claim0 of 5 sources checked
    • cites [14] C Young, 2000, Docosahexaenoic acid inhibits synaptic transmission and epileptiform activity in the rat hippocampus, Synapse source

      Not checked in the free run.

    • cites [15] AE Musto, 2011, The omega-3 fatty acid-derived neuroprotectin D1 limits hippocampal hyperexcitability and seizure susceptibility in kindling epileptogenesis, Epilepsia source

      Not checked in the free run.

    • cites [12] NG Bazan, 2011, Docosahexaenoic acid signalolipidomics in nutrition: significance in aging, neuroinflammation, macular degeneration, Alzheimer’s, and other neurodegenerative diseases, Annu Rev Nutr source

      Not checked in the free run.

    • cites [16] NG Bazan, 2010, Rescue and repair during photoreceptor cell renewal mediated by docosahexaenoic acid-derived neuroprotectin D1, J Lipid Res source

      Not checked in the free run.

    • cites [17] L Belayev, 2009, Robust docosahexaenoic acid-mediated neuroprotection in a rat model of transient, focal cerebral ischemia, Stroke source

      Not checked in the free run.

  • May combine two claims.

    Premisecitation

    NPD1 promotes cell survival and homeostasis regulation during cellular damage.

    “NPD1 promotes cell survival and homeostasis regulation during cellular damage [18].”
    Quote in the paperSubstantial claim0 of 1 sources checked
    • cites [18] NG Bazan, 2012, Neuroinflammation

      Not checked in the free run.

  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Premisecitation

    NPD1 attenuates damage resulting from ischemia-reperfusion.

    “The stereoselective mediator neuroprotectin D1 (NPD1; 10R,17S-dihydroxy-docosa-4Z,7Z,11E,13E,15Z,19Z-hexaenoic acid) has been shown to attenuate damage resulting from ischemia-reperfusion [19].”
    Quote in the paperNot a substantial claim0 of 1 sources checked
    • cites [19] VL Marcheselli, 2003, Novel docosanoids inhibit brain ischemia-reperfusion-mediated leukocyte infiltration and pro-inflammatory gene expression, J Biol Chem source

      Not checked in the free run.

  • May combine two claims.

    Premisecitation

    There are no effective treatments or preventive/disease-modifying therapies for TLE or epileptogenesis.

    “Aside from neurosurgical resection, which benefits only a small population of TLE patients [2], there are no other effective treatments or preventive strategies for TLE [3].”
    • Also stated in: § Introduction · plain
      “Unfortunately, there is no current effective treatment that prevents, or a disease-modifying therapy for epileptogenesis.”
    Quote in the paperSubstantial claim0 of 2 sources checked
    • cites [2] N Jette, 2013, Update on the surgical treatment of epilepsy, Curr Opin Neurol source

      Not checked in the free run.

    • cites [3] R Mani, 2011, Human clinical trails in antiepileptogenesis, Neurosci Lett source

      Not checked in the free run.

  • Classified as probably not a substantial claim.

    Premisecitation

    DHA-derived docosanoids mediate neuroprotective bioactivity.

    “DHA-derived docosanoids mediate neuroprotective bioactivity [18].”
    Quote in the paperSubstantial claim0 of 1 sources checked
    • cites [18] NG Bazan, 2012, Neuroinflammation

      Not checked in the free run.

  • Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.

    Premisecitation

    Most antiepileptic drugs act by inhibiting voltage-gated sodium or calcium channels or potentiating GABA-mediated synaptic transmission, resulting in a symptomatic approach.

    “Although, there is an abundance of diverse antiepileptic drugs, most of them exert their actions by inhibition of the voltage-gated sodium or calcium channels or by potentiation of the GABA-mediated synaptic transmission [11], which results in a symptomatic approach in most cases; the goal of these drugs is to eliminate or at least reduce the number and/or severity of seizures.”
    Quote in the paperNot a substantial claim0 of 1 sources checked
    • cites [11] M Bialer, 2013, Progress report on new antiepileptic drugs: a summary of the Eleventh Eilat Conference (EILAT XI), Epilepsy Res source

      Not checked in the free run.

  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Premisecitation

    DHA is concentrated and avidly retained in phospholipids of synaptic and other neural membranes.

    “Docosahexaenoic acid (DHA), an omega-3 essential fatty acid family member, is concentrated and avidly retained in phospholipids of synaptic and other neural membranes [12, 13].”
    Quote in the paperNot a substantial claim0 of 2 sources checked
    • cites [12] NG Bazan, 2011, Docosahexaenoic acid signalolipidomics in nutrition: significance in aging, neuroinflammation, macular degeneration, Alzheimer’s, and other neurodegenerative diseases, Annu Rev Nutr source

      Not checked in the free run.

    • cites [13] NG Bazan, 2011, Endogenous signaling by omega-3 docosahexaenoic acid-derived mediators sustains homeostatic synaptic and circuitry integrity, Mol Neurobiol source

      Not checked in the free run.

  • May combine two claims.

    Premisecitation

    Seizure progression severity and hippocampal hyperexcitability are attenuated upon intraventricular administration of NPD1.

    “Moreover, seizure progression severity and hippocampal hyperexcitability are attenuated upon intraventricular administration of NPD1 [15].”
    Quote in the paperSubstantial claim0 of 1 sources checked
    • cites [15] AE Musto, 2011, The omega-3 fatty acid-derived neuroprotectin D1 limits hippocampal hyperexcitability and seizure susceptibility in kindling epileptogenesis, Epilepsia source

      Not checked in the free run.

  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Premisecitation

    Hippocampal hyper-excitability is a paroxysmal and self-limited neuronal network phenomenon characterized by the hyper-synchrony of a large population of neurons.

    “Hippocampal hyper-excitability represents a paroxysmal and self-limited neuronal network phenomenon characterized by the hyper-synchrony of a large population of neurons [51]”
    Quote in the paperNot a substantial claim0 of 1 sources checked
    • cites [51] S Osawa, 2013, Optogenetically induced seizure and the longitudinal hippocampal network dynamics, PLoS One source

      Not checked in the free run.

  • May combine two claims.

    Study design and conductown data

    The number of samples and their duration between vehicle and NPD1-treated animals were not statistically significant.

    “The number of samples and their duration between vehicle and NPD1-treated animals were not statistically significance (p = 0.2; p = 0.3 respectively).”
    Quote in the paperNot a substantial claim
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Study design and conductown data

    Delta epochs were selected by an investigator blinded to treatment.

    “Then delta epochs (5–6 seconds each) (Fig. 2A) from each local field potential were determined by periods of immobility, without artifacts or noise, selected by an investigator blinded to the treatment, and confirmed by reproduction of video recordings and by calculating the ratio of delta and theta frequency bands in the CA1 hippocampal region [27].”
    Quote in the paperNot a substantial claim
  • May combine two claims.

    Premisecitation

    The pilocarpine model of temporal lobe epilepsy in adult mice shows an onset of recurrent spontaneous seizures 7 days after status epilepticus that can continue for at least 7 weeks.

    “The pilocarpine model of TLE in adult mice shows an onset of recurrent spontaneous seizures 7 days after SE that can continue for at least 7 weeks [27, 34, 35].”
    Quote in the paperSubstantial claim0 of 3 sources checked
    • cites [27] J Csicsvari, 1998, Reliability and state dependence of pyramidal cell-interneuron synapses in the hippocampus: an ensemble approach in the behaving rat, Neuron source

      Not checked in the free run.

    • cites [34] J Seo, 2012, Early deficits in social behavior and cortical rhythms in pilocarpine-induced mouse model of temporal lobe epilepsy, Exp Neurol S0014–4886

      Not checked in the free run.

    • cites [35] H Shibley, 2002, Pilocarpine-induced status epilepticus results in mossy fiber sprouting and spontaneous seizures in C57BL/6 and CD-1 mice, Epilepsy Res source

      Not checked in the free run.

  • May combine two claims.

    Premisecitation

    After intra-ventricular administration of NPD1 during kindling epileptogenesis, NPD1 limits progression of seizure severity and hippocampal hyper-excitability, including abnormal patterns of the electrical seizures.

    “After intra-ventricular administration of NPD1 during kindling epileptogenesis, we observed that NPD1 limits progression of seizure severity and hippocampal hyper-excitability, including abnormal patterns of the electrical seizures [15]”
    Quote in the paperSubstantial claim0 of 1 sources checked
    • cites [15] AE Musto, 2011, The omega-3 fatty acid-derived neuroprotectin D1 limits hippocampal hyperexcitability and seizure susceptibility in kindling epileptogenesis, Epilepsia source

      Not checked in the free run.

  • Classified as probably not a substantial claim.

    Study design and conductcitation

    Histological verification of probe placement in the dorsal hippocampus was confirmed by histology.

    “At the end of the experiment, histological verification of probe placement in the dorsal hippocampus was confirmed by histology [29] for anatomic-physiological correlation of different hippocampal layers [21].”
    Quote in the paperSubstantial claim0 of 2 sources checked
    • cites [29] AE Musto, 2009, Different phases of afterdischarge during rapid kindling procedure in mice, Epilepsy Res source

      Not checked in the free run.

    • cites [21] G Buzsáki, 2003, Hippocampal network patterns of activity in the mouse, Neuroscience source

      Not checked in the free run.

  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Study design and conductnone given

    Each group had an equal number of analyzed dendrites.

    “Each group had an equal number of analyzed dendrites.”
    Quote in the paperNot a substantial claim
  • Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.

    Study design and conductown data

    Studies were performed according to National Institutes of Health and ARRIVE guidelines and IACUC approved protocols.

    “Studies were performed according to National Institutes of Health and ARRIVE guidelines and in accordance with nationally accepted principles in the care and use of experimental animals. The Institutional Animal Care and Use Committee (IACUC) at the Louisiana State University Health Sciences Center (LSUHSC), New Orleans, approved the animal protocols used for this study.”
    Quote in the paperNot a substantial claim
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Study design and conductown data

    Animals were randomized to treatment groups.

    “Then surviving animals (n = 45, 60%) were randomized and placed in individual cages until surgery and/or further treatment (Fig. 1A).”
    Quote in the paperNot a substantial claim
  • Classified as probably not a substantial claim.

    Premisecitation

    Dendritic spines are a morphological signature of post-synaptic sites.

    “dendritic spines are thought to be a morphological signature of post-synaptic sites [36]”
    Quote in the paperSubstantial claim0 of 1 sources checked
    • cites [36] R Yuste, 2011, Dendritic spines and distributed circuits, Neuron source

      Not checked in the free run.

  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Study design and conductown data

    Dendritic spine analysis was done by investigators blinded to experimental conditions.

    “Analysis of the number of dendritic spines was done using Image J software (National Institute of Health) by investigators blinded to the experimental conditions.”
    Quote in the paperNot a substantial claim
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Premisecitation

    BDNF, NGF, NT3 and other neurotrophins are NPD1-synthesis agonists.

    “since BDNF, NGF, NT3 and other neurotrophins are NPD1-synthesis agonists”
    Quote in the paperNot a substantial claim0 of 1 sources checked
    • cites [57] PK Mukherjee, 2007, Neurotrophins enhance retinal pigment epithelial cell survival through neuroprotectin D1 signaling, Proc Natl Acad Sci USA source

      Not checked in the free run.

  • May combine two claims.

    Premisecitation

    NPD1 modulates neuroinflammatory signaling and reduces oxidative stress-induced apoptosis by modulating pro-inflammatory gene expression and the Bcl-2 family of proteins.

    “NPD1 modulates neuroinflammatory signaling and reduces oxidative stress-induced apoptosis by modulating pro-inflammatory gene expression and the Bcl-2 family of proteins [18, 56].”
    Quote in the paperSubstantial claim0 of 2 sources checked
    • cites [18] NG Bazan, 2012, Neuroinflammation

      Not checked in the free run.

    • cites [56] NG Bazan, 2012, Lipid mediators: Eicosanoids, docosanoids and platelet-activating factor

      Not checked in the free run.

  • May combine two claims.

    Interpretationown data

    Hippocampal hyper-excitability could be initiated by bursts of pathological high-frequency oscillations and modulated by NPD1, resulting in decreased MEA.

    “that could be initiated by bursts of pHFO and modulated by NPD1 resulting in decreased MEA (Fig. 5).”
    Quote in the paperSubstantial claim
  • May combine two claims.

    Interpretationreasoning

    NPD1 administration could initiate or strengthen endogenous neuroprotective signaling in dendritic spines and limit their damage.

    “Therefore, NPD1 administration could also initiate or strengthen endogenous neuroprotective signaling in dendritic spines and limit their damage.”
    Quote in the paperNot a substantial claim
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Premisecitation

    Epileptiform activity during initiation of epileptic discharges in the neocortex suggests enhanced postsynaptic activity.

    “Epileptiform activity during initiation of epileptic discharges in the neocortex [52] suggests enhanced postsynaptic activity [53].”
    Quote in the paperNot a substantial claim0 of 2 sources checked
    • cites [52] AB Chatt, 1982, The laminar sensitivity of cat striate cortex to penicillin induced epileptogenesis, Brain Res source

      Not checked in the free run.

    • cites [53] R Galvez, 2006, Vibrissa-signaled eyeblink conditioning induces somatosensory cortical plasticity, J Neurosci source

      Not checked in the free run.

  • Classified as probably not a substantial claim.

    Premisecitation

    Local field potentials represent post-synaptic potential activities from synchronized neurons.

    “Because LFPs represent post-synaptic potential activities from synchronized neurons [21]”
    Quote in the paperSubstantial claim0 of 1 sources checked
    • cites [21] G Buzsáki, 2003, Hippocampal network patterns of activity in the mouse, Neuroscience source

      Not checked in the free run.

  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Interpretationcitation

    Dendritic spine rearrangement could result from seizure-induced dendritic spine loss.

    “Moreover, dendritic spine rearrangement could result from seizure-induced dendritic spine loss [55].”
    Quote in the paperNot a substantial claim0 of 1 sources checked
    • cites [55] MP Mattson, 1999, “Apoptotic” biochemical cascades in synaptic compartments: roles in adaptive plasticity and neurodegenerative disorders, J Neurosci Res source

      Not checked in the free run.

  • Classified as probably not a substantial claim.

    Study design and conductnone given

    Seizure quantification was performed by an investigator blinded to treatment.

    “Then the number of spontaneous motor seizures (stage 3 or and 4), according to the Racine’s score [25], and their durations were quantified each day (5–6 hours) by an investigator blinded to the treatment, and then the total number of those seizures was summarized for each animal.”
    Quote in the paperSubstantial claim
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Premisecitation

    Dendritic swelling and beading are hallmarks of dendritic injury.

    “dendritic swelling and beading, both of which are hallmarks of dendritic injury [38]”
    Quote in the paperNot a substantial claim0 of 1 sources checked
    • cites [38] X Gao, 2011, Moderate traumatic brain injury causes acute dendritic and synaptic degeneration in the hippocampal dentate gyrus, PLoS One source

      Not checked in the free run.

  • May combine two claims.

    Interpretationown data

    NPD1 provides effective neuroprotection that down-regulates epileptogenesis and rescues vulnerable cellular and sub-cellular structures after status epilepticus.

    “our studies here show that NPD1 provides effective neuroprotection that down-regulates epileptogenesis and rescues vulnerable cellular and sub-cellular structures after SE.”
    Quote in the paperSubstantial claim
  • May combine two claims.

    Interpretationcitation

    NPD1 could downregulate cyclooxygenase-2 expression during epileptogenesis and limit neuroinflammatory-mediated damage.

    “In addition, it could downregulate cyclooxgenase-2 expression during epileptogenesis [58] and limit neuroinflammatory-mediated damage [19, 56].”
    Quote in the paperSubstantial claim0 of 3 sources checked
    • cites [58] B Tu, 2003, Hippocampal kindling epileptogenesis upregulates neuronal cyclooxygenase-2 expression in neocortex, Exp Neurol

      Not checked in the free run.

    • cites [19] VL Marcheselli, 2003, Novel docosanoids inhibit brain ischemia-reperfusion-mediated leukocyte infiltration and pro-inflammatory gene expression, J Biol Chem source

      Not checked in the free run.

    • cites [56] NG Bazan, 2012, Lipid mediators: Eicosanoids, docosanoids and platelet-activating factor

      Not checked in the free run.

35 of 35
  • The paper relies on this without support.

    NPD1 administered intraperitoneally at 570 μg/kg for five consecutive days reaches the hippocampus and engages neuroprotective signaling.

    “NPD1 and vehicle solutions were prepared according to previous protocols [30], and then NPD1 (570 μg/kg) or vehicle was administered i.p. once a day for five consecutive days 24 hours after termination of SE.”
  • The paper relies on this without support.

    Dendritic spine number measured by Golgi staining is a valid proxy for synaptic integrity and network function.

    “Then the number of dendritic spines (irrespective of their morphological characteristics that emerged perpendicular from the dendritic shaft) for each segment of the dendrite (10 μm) was quantified according to established procedures using Image J software (National Institute of Health) [31].”
  • The paper relies on this without support.

    The vehicle solution is inert and does not affect hippocampal networks or seizures.

    “NPD1 (570 μg/kg) or vehicle was administered intraperitoneally daily for five consecutive days 24 hours after termination of SE.”
3 of 3

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

  • Survival percentage does not match the reported mouse counts

    Minor

    The methods report 52 mice receiving pilocarpine and 45 surviving. That is 86.5%, not 60%.

    Reported 60 · recomputed 86.538462

1 of 1

Cites

Flagged first, then by citations

Research works printed but not linked: 1

  1. B Tu, 2003, Hippocampal kindling epileptogenesis upregulates neuronal cyclooxygenase-2 expression in neocortex, Exp Neurol, 179, 167

Authors
Musto, A. E., Walker, C. P., Petasis, N. A., & Bazan, N. G.
Affiliations
  • Louisiana State University Health Sciences Center New Orleans (US)
  • University of Southern California (US)
Corresponding author
  • Musto, Alberto E.
  • Bazan, Nicolas G.
Venue
PLOS ONE
Published
2015-01-24
Volume
10
Issue
1
Pages
e0116543
ISSN
1932-6203 (ISSN-L)
OpenAlex
W2062037597
Cited by
39
References
59
Citations by year
2026: 1 · 2025: 7 · 2024: 7 · 2023: 4 · 2022: 3 · 2021: 3 · 2020: 2 · 2019: 3 · 2018: 3 · 2017: 3 · 2016: 1 · 2015: 2
FWCI
2.44
Type
journal article
Language
en
Open access
Locations
  • PLoS ONE (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
  • Figshare (submittedVersion, cc-by)
Funders
  • National Institutes of Health (GM-103340)
  • National Institute of General Medical Sciences (GM-103340, P30GM103340)
Topics
  • Health Sciences › Medicine › Psychiatry and Mental health › Epilepsy research and treatment
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
  • Health Sciences › Medicine › Physiology › Diet and metabolism studies
Keywords
neuroprotectin D1, epileptogenesis, limbic epilepsy, temporal lobe epilepsy, status epilepticus, pilocarpine, dendritic spines, docosahexaenoic acid, lipid mediators, spontaneous seizures
MeSH terms
Animals, Docosahexaenoic Acids, Epilepsy, Temporal Lobe, Hippocampus, Limbic System, Male, Mice, Inbred C57BL, Nerve Net, Pilocarpine, Status Epilepticus, Dendritic Spines, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Claims read by deepseek-v4.1-flash under definition version 3 (extract-v3) on 2026-10-09.

Classified by jev-1.13-20260917 (gold-guideline-v0.2) on 2026-10-09.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review